New Survey: Consumers Hold Drug Companies Responsible for High Prices and Out-of-Pocket Costs

Wednesday, November 30, 2016 Drug News
Email Print This Page Comment
Font : A-A+

Drugmakers' Campaign to Deflect Blame for High Prices Falls Flat

WASHINGTON, Nov. 30, 2016 /PRNewswire-USNewswire/ -- A new national survey finds most voters blame drug companies

not only for high drug prices, but also for out-of-pocket costs. The findings undermine the drug industry's $100 million PR campaign to blame higher costs on employers, unions, health plans and the pharmacy benefit managers (PBMs) they use to negotiate discounts on prescription drugs.

"Consumers are well aware drug companies set drug prices and they know higher prices mean higher out-of-pocket costs. No one's buying the drug companies' campaign to shift blame to employers, unions, plans, or the PBMs that negotiate discounts on their behalf," said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt.

North Star Opinion Research surveyed 1,000 registered voters nationwide.

Key findings from survey include:

  • By almost 3-to-1, voters blame high drug prices for increased cost-sharing.
  • Only 1-in-5 voters buy the drugmakers' "rebates cause high prices" message.
  • Three-quarters of voters say the cost of prescription drugs is too high.
  • More than 4-of-5 voters with prescription drug coverage are satisfied with it.

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-survey-consumers-hold-drug-companies-responsible-for-high-prices-and-out-of-pocket-costs-300370621.html

SOURCE Pharmaceutical Care Management Association



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook